Acomon Clinical Research Organization Home
Tuesday, January 06, 2009 | Register | Login |   Search      
 

Clinical Management Services
Using a focused, passionate approach to how clinical studies are performed, Acromon Clinical Research Organization helps fill the need among virtual, emerging and medium sized pharmaceutical companies for experienced teams to design and execute the clinical portion of the drug development process. Acromon provides clinical research services to sponsors from inception of clinical concept and its implementation to final report writing, FDA submission and defense.

As part of the Azopharma Product Development Group™ of companies, we can also support all of your product development needs. From discovery to commercialization, Azopharma is your product development partner. Acromon operates independently to effectively design and monitor clinical trials in an unbiased fashion.

 

  • Non-clinical Development and Protocol Design -
    Acromon excels at providing services to help your organization prepare for a clinical trial program.
  • Data Management -
    Acromon also provides full data management services to ensure the accuracy of your results.
  • Clinical Monitoring -
    Ensuring the safety of your patients and integrity of your data is our number one goal! To support this, Acromon provides complete clinical monitoring services.
  • Biostatistical Analysis -
    Acromon has comprehensive capabilities to generate and analyze your data.
  • Final Clinical Study Report Writing -
    Acromon has all-inclusive services to prepare your data for regulatory submission.
  • Clinical Pharmacology -
    Through Avivoclin Clinical Services we provide inpatient and outpatient trials for Phase I-III trials.
  • Formulation Services -
    Through our parent company, Azopharma Product Development Group, we provide full formulation services for all major dosage forms in support of your clinical pharmacology studies.
  • CTM Manufacturing -
    Through the Azopharma Product Development Group we provide full CTM manufacturing services across all major dosage forms.
 
Press Releases

November 11, 2008

Azopharma Unveils New UK Laboratory and EU plans 

HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the European market with the addition of new laboratory facilities and office space located in Welwyn Garden City, UK. The new facility will provide analytical, QP release testing, preformulation and formulation development services to the European market.
 
Mr. Phil Meeks, CEO of Azopharma Product Development Group says, “This is a very exciting time for Azopharma with our first venture outside the USA. Our vision for the new laboratory is to provide key product development services to our many clients in Europe. We see this facility as the first step in bringing our complete service offerings to the region.” Read More

 

Trade Shows

AAPS
Atlanta, GA
November 17-20





Copyright 2007 Acromon   Terms Of Use   Privacy Statement   Site Map